XM28Y3ICD-11 MMS 2026-01
Alseroxylon
Index terms
- Alseroxylon
- Rautensin
- Rauwiloid
Sibling codes
XM00F2– SaralasinXM01D4– RaudixinXM0CY8– ApresolineXM0YY0– KetanserinXM1AF9– Agents affecting arteriolar smooth muscleXM1F18– MetirosineXM1GS9– Protoveratrine (s) (A) (B)XM1LN2– HarmonylXM1TT7– DHE 45XM1U35– PargylineXM24X9– DihydrazineXM2PT6– Antihypertensive drugXM2W66– Sodium nitroprussideXM3HS0– TeprotideXM3WP0– Antagonist serotoninXM48R9– VeratrineXM4EP4– Hypotensive drugXM4FW8– Benazepril hydrochlorideXM4NN7– AlkavervirXM4X84– Centrally acting antiadrenergic agentsXM5E71– BudralazineXM5ET8– GuanaclineXM5FH0– RautotalXM5JL6– GuanadrelXM5PW7– RauwoldinXM5T36– TodralazineXM6E07– SerpasilXM6T97– AmiquinsinXM74W2– RautinaXM7HA8– ModerilXM7NT3– Ganglion-blocking antiadrenergic agentsXM7NV2– GuanabenzXM7TE8– GuanoctineXM7W35– MethyldopateXM8AK5– SyrosingopineXM8BQ9– VeratrumXM8SX7– Peripherally acting antiadrenergic agentsXM9W04– Cryptenamine (tannates)
Foundation entity
Part of: XM3973: Agents primarily affecting the cardiovascular system › XM6S30: Medicaments › X: Extension Codes